<DOC>
	<DOCNO>NCT00524394</DOCNO>
	<brief_summary>Infants NICU high risk morbidity mortality infection onset . Diagnosis infection imperfect best . Patterns inflammatory regulatory protein ( cytokine &amp; chemokines , addition antigen detection antibody secrete cell ( ASC 's ) may provide accurate rapid approach diagnosis infection high-risk patient .</brief_summary>
	<brief_title>Characteristics Cord Blood Immunologic Parameters Infants &lt; 32 Weeks Gestation</brief_title>
	<detailed_description>Sampling methods/Data collection Samples : Serum ( 1-2ml ) enrol infant collect cord blood ( T0 ) . Serial sample ( 0.5-1ml ) collect 3 time : T1= 4-7 day , T2=10-14 day , T3= 20-30 day . These draw initiation sepsis work-up , prior transfusion PRBC 's blood ≥0.5ml waste . These collection intend analyze immunologic milieu infant various stage natal post-natal immune adaptation : 1. baseline level relatively privilege environment ( cord blood T0 ) 2. peak immunogenic response prenatal exposure ( T1 ) 3. plateau immunogenic response perinatal exposure ( T2 ) 4. relative state equilibrium surround flora ( T3 ) Data collection : Baseline statistic enrollment : Birth weight , obstetrical assessment gestational age , mode delivery , presence labor , presence IAI , ROM , intrapartum antibiotic type length , With sampling , data gather via chart review infant . We also gather data 60 DOL , discharge , death infant enrol . Measurements : Experimental laboratory : Cytokines- Each sample plasma analyze Luminex ( Biorad ) determine profile cytokine : IL-2 , IL-6 , IL-8 , IL-13 , MIP1b , MCP1 , IL-1b , IL-4 , IL-5 , IL-7 , IL-10 , IL-12p70 , IL-17 , GMCSF , IFN-gamma , TNF-alpha . Standard curve cytokine measurement run determine upper low limit detection . ASC- quantified enzyme-linked immunospot assay ( ELISPOT ) specific isotypes IgA , IgM , IgG . They also link 3 particular immunogenic agent : GBS , Candida , CoNS . Clinical laboratory : Total WBC band ratio run routine course care infant . This additional sample . serious bacterial infection sepsis ( meningitis , UTI ) - Course Study- 0-30 day life sample . 0-60 day life data collection . - Enrollment- consecutive admission NICU follow criterion Inclusion : Admitted NICU MHCH - 1500gm ≤ 32 wk GA Birth &lt; 31 day life time enrollment Exclusion : Known suspected immunodeficiency ( include maternal HIV know congenital infection ) Known major congenital anomaly - Recruitment Will include eligible infant primary investigator co-investigators . Assuming incidence LOS ~25 % EOS ~1-3 % , power 80 % , enroll 50 infant . This coincide prior study evaluate ASC 's response neonate , evaluate cytokine cord blood post-natally . - Known Risks There additional blood draw . There collection great volume blood ( additional 0.5ml-1.0ml depend size infant ) clinical indication blood draw . No clinical decision make base data obtain .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<criteria>Infants bear Children 's Memorial Hermann Hospital cord blood available &lt; 1500gm &lt; 32 week gestation OB estimate Outborn infant transfer CMHH without cord blood available Parents consent &gt; 1500gm &gt; 32 week gestation OB estimate</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Days</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>VLBW</keyword>
	<keyword>sepsis</keyword>
	<keyword>diagnosis</keyword>
	<keyword>suspect sepsis</keyword>
</DOC>